Structures by: Parvez M.
Total: 636
Enoxacin
C15H17FN4O3,3H2O
Acta Crystallographica Section C (2004) 60, 4 o281-o283
a=13.618(3)Å b=7.2963(13)Å c=18.316(5)Å
α=90.00° β=108.282(12)° γ=90.00°
Α-epoxide
C32H52O4
Acta Crystallographica Section C (2007) 63, 4 o249-o251
a=11.483(4)Å b=7.612(3)Å c=16.903(6)Å
α=90.00° β=95.79(3)° γ=90.00°
Β-epoxide
C32H52O4
Acta Crystallographica Section C (2007) 63, 4 o249-o251
a=13.356(6)Å b=6.233(13)Å c=18.104(16)Å
α=90.00° β=92.14(7)° γ=90.00°
7-phenyl-1-oxa-4-thiaspiro[4.5]decan-7-ol
C14H18O2S
Acta Crystallographica Section C (2001) 57, 5 577-579
a=12.313(2)Å b=10.674(5)Å c=19.535(2)Å
α=90° β=90° γ=90°
7-phenyl-1-oxa-4-thiaspiro[4.5]decan-7-ol
C14H18O2S
Acta Crystallographica Section C (2001) 57, 5 577-579
a=22.136(8)Å b=10.144(2)Å c=24.923(6)Å
α=90° β=114.17(2)° γ=90°
Clemizoledichlorocobalt(II)
C19H20Cl3CoN3
Acta Crystallographica Section C (2000) 56, 8 919-920
a=9.647(6)Å b=12.675(6)Å c=16.359(5)Å
α=90.00° β=93.77(4)° γ=90.00°
1-Oxa-4-thiaspiro[4.5]decane
C19H23BrO3S
Acta Crystallographica Section C (2001) 57, 1 79-81
a=7.243(2)Å b=11.5410(10)Å c=22.180(5)Å
α=90.00° β=94.09(2)° γ=90.00°
Doxylamine tetrachlorocuprate(II)
C17H24N2O2,CuCl42
Acta Crystallographica Section C (2001) 57, 3 262-263
a=16.807(2)Å b=9.3006(16)Å c=13.7677(10)Å
α=90.00° β=106.682(10)° γ=90.00°
2-[(3,4-dimethylphenyl)carbamoyl]benzenesulfonamide
C15H16N2O3S
Acta Crystallographica Section C (2008) 64, 7 o367-o371
a=11.597(9)Å b=7.450(3)Å c=16.324(13)Å
α=90.00° β=97.29(3)° γ=90.00°
2-[(2,6-dimethylphenyl)carbamoyl]benzenesulfonamide
C15H16N2O3S
Acta Crystallographica Section C (2008) 64, 7 o367-o371
a=7.968(3)Å b=8.509(5)Å c=21.510(11)Å
α=84.30(2)° β=82.46(3)° γ=88.66(3)°
2-[(2,3-dimethylphenyl)carbamoyl]benzenesulfonamide
C15H16N2O3S
Acta Crystallographica Section C (2008) 64, 7 o367-o371
a=12.842(7)Å b=15.153(9)Å c=7.572(4)Å
α=90.00° β=91.16(4)° γ=90.00°
(N-Maleoylglycinate)trimethyltin(IV)
[Sn(CH3)3(C6H4NO4)]
Acta Crystallographica Section C (2000) 56, 3 327-328
a=6.5848(15)Å b=9.991(4)Å c=19.688(6)Å
α=90.00° β=93.31(3)° γ=90.00°
Caulerpin
C24H18N2O4
Acta Crystallographica Section C (2000) 56, 3 e96-e97
a=19.608(4)Å b=4.786(2)Å c=20.461(6)Å
α=90.00° β=97.91(2)° γ=90.00°
N-(2-Chlorobenzyl)-1,2,3,4-tetrahydroisoquinoline-1,3-dione
C16H12ClNO2
Acta Crystallographica Section C (2002) 58, 3 o164-o167
a=7.7922(14)Å b=21.538(4)Å c=24.351(5)Å
α=90° β=98.92(2)° γ=90°
N-(2-Bromo-4-methylphenyl)-1,2,3,4-tetrahydroisoquinoline-1,3-dione
C16H12Br1N1O2
Acta Crystallographica Section C (2002) 58, 3 o164-o167
a=15.847(2)Å b=7.9190(7)Å c=11.0602(11)Å
α=90° β=94.750(9)° γ=90°
N-(2,3-Dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline-1,3-dione
C15H9Cl2N1O2
Acta Crystallographica Section C (2002) 58, 3 o164-o167
a=15.6702(8)Å b=6.1560(5)Å c=14.5889(7)Å
α=90° β=112.236(4)° γ=90°
9-(4-vinylbenzyl)adenine
C14H13N5
Acta Crystallographica Section C (2002) 58, 7 o378-o380
a=5.28850(10)Å b=8.1643(2)Å c=28.8446(5)Å
α=90.00° β=90.00° γ=90.00°
1-(4-vinylbenzyl)uracil
C13H12N2O2
Acta Crystallographica Section C (2002) 58, 7 o378-o380
a=5.9603(2)Å b=7.0132(2)Å c=25.9571(9)Å
α=90.00° β=90.00° γ=90.00°
3-(2-tolyl)-3-(tri-4-tolylgermyl)propionic acid
C31H32GeO2
Acta Crystallographica Section C (2002) 58, 11 m559-m562
a=10.984(3)Å b=13.710(4)Å c=20.245(5)Å
α=90° β=113.857(14)° γ=90°
3-(2-fluorophenyl)-3-(triphenylgermyl)propionic acid
C27H23FGeO2
Acta Crystallographica Section C (2002) 58, 11 m559-m562
a=9.7278(10)Å b=17.907(3)Å c=13.541(2)Å
α=90° β=110.907(8)° γ=90°
3-(tribenzylgermyl)-3-(4-tolyl)propionic acid
C31H32GeO2
Acta Crystallographica Section C (2002) 58, 11 m559-m562
a=10.476(2)Å b=16.337(3)Å c=15.119(5)Å
α=90° β=92.018(8)° γ=90°
Stilbene
C15H10N4O9
Acta Crystallographica Section C (2003) 59, 3 o156-o158
a=7.096(4)Å b=8.550(3)Å c=28.101(5)Å
α=90.00° β=90.87(3)° γ=90.00°
2-(4-chlorophenyl)-4-(2-hydroxylphenyl)-2-phenyl-2,3-dihydro-1,5- benzothiazepine
C21H16ClNOS
Acta Crystallographica Section C (2003) 59, 6 o298-o301
a=18.036(9)Å b=4.836(2)Å c=19.790(11)Å
α=90.00° β=97.02(2)° γ=90.00°
4-(2-hydroxylphenyl)-2-(4-methoxyphenyl)-2-phenyl-2,3-dihydro-1,5- benzothiazepine
C22H19NO2S
Acta Crystallographica Section C (2003) 59, 6 o298-o301
a=11.973(2)Å b=16.224(4)Å c=9.250(3)Å
α=90.00° β=94.437(9)° γ=90.00°
4-(2-hydroxylphenyl)-2-phenyl-2-(4-tolyl)-2,3-dihydro-1,5-benzothiazepine
C22H19NOS
Acta Crystallographica Section C (2003) 59, 6 o298-o301
a=4.8678(11)Å b=17.563(3)Å c=20.129(5)Å
α=90.00° β=93.078(8)° γ=90.00°
18-deoxy-13β,14-dihydrolycoctam
C23H35NO4
Acta Crystallographica Section C (2006) 62, 5 o283-o285
a=9.675(5)Å b=10.401(6)Å c=11.063(7)Å
α=90.00° β=110.86(3)° γ=90.00°
Tetrakis(1-naphthylamino)silane
C40H32N4Si
Acta Crystallographica Section C (2007) 63, 11 o617-o619
a=10.695(2)Å b=22.718(4)Å c=13.516(2)Å
α=90.00° β=109.500(10)° γ=90.00°
Tetrakis(1-naphthylamino)silane tetrahydrofuran trisolvate
C40H32N4Si,3C4H8O
Acta Crystallographica Section C (2007) 63, 11 o617-o619
a=21.048(7)Å b=14.672(7)Å c=15.160(9)Å
α=90.00° β=104.46(2)° γ=90.00°
Tetrabutylbis(N-phthaloylglycinato)distannoxane dimer
[Sn4(C4H9)8(C10H6NO4)4O2]
Acta Crystallographica Section C (2000) 56, 2 159-160
a=13.344(5)Å b=14.393(4)Å c=11.683(2)Å
α=93.51(3)° β=110.00(2)° γ=64.19(2)°
(2E)-3-(2-chloro-6-methylquinolin-3-yl)-1-(5-iodothiophen-2-yl)prop-2-en-1-one,
C17H11ClINOS
Acta Crystallographica Section C (2008) 64, 10 o547-o549
a=17.112(6)Å b=7.636(3)Å c=13.174(5)Å
α=90.00° β=111.29(2)° γ=90.00°
(2E)-3-(2-chloro-6-methylquinolin-3-yl)-1-(5-methylfuran-2-yl)prop-2-en-1-one
C18H14ClNO2
Acta Crystallographica Section C (2008) 64, 10 o547-o549
a=36.228(10)Å b=7.372(3)Å c=11.214(5)Å
α=90.00° β=99.70(2)° γ=90.00°
2-Methyl-3-(methylsulfonyl)benzo[b]thiophene
C10H10O2S2
Acta Crystallographica Section C (2000) 56, 5 574-576
a=5.8228(5)Å b=10.4400(10)Å c=8.6217(9)Å
α=90.00° β=99.570(10)° γ=90.00°
2,5-bis(methylthio)-1,4-benzoquinone
C8H8O2S2
Acta Crystallographica Section C (2000) 56, 5 574-576
a=4.032(2)Å b=5.7170(10)Å c=9.6260(10)Å
α=86.040(10)° β=80.60(2)° γ=86.09(3)°
Clarithromycin Hydrochloride 3.5 Hydrate
C38H70NO131,Cl1,3.5H2O
Acta Crystallographica Section C (2000) 56, 9 e398-e399
a=14.409(2)Å b=16.489(3)Å c=19.267(3)Å
α=90.00° β=90.00° γ=90.00°
Astemizole tetrachlorocuprate(II)
C28H33FN4O2,CuCl42
Acta Crystallographica Section C (2000) 56, 10 1216-1217
a=9.1099(7)Å b=15.9279(15)Å c=20.5073(19)Å
α=90.00° β=100.445(2)° γ=90.00°
N-phenylmaleimide adduct of 1-oxa-4-thia-6-vinyl-spiro[4.5]dec-6-ene
C20H21NO3S
Acta Crystallographica Section C (2001) 57, 1 82-85
a=12.047(2)Å b=7.808(2)Å c=9.7180(10)Å
α=90.00° β=108.710(10)° γ=90.00°
Dimethylacetylene dicarboxylate adduct of 1-oxa-4-thia-6-vinyl-spiro[4.5]dec-6-ene
C16H20O5S
Acta Crystallographica Section C (2001) 57, 1 82-85
a=6.812(3)Å b=10.494(7)Å c=11.023(5)Å
α=96.014(7)° β=90.970(10)° γ=90.21(2)°
N-Methyl-1,3,4-triazoline-2,5-dione adduct of 1-oxa-4-thia-6-vinyl-spiro[4.5]dec-6-ene
C13H17N3O3S
Acta Crystallographica Section C (2001) 57, 1 82-85
a=13.258(2)Å b=7.3897(17)Å c=14.2874(13)Å
α=90.00° β=105.944(9)° γ=90.00°
1-Oxa-4-thiaspiro[4.5]decane
C19H24O3S
Acta Crystallographica Section C (2001) 57, 1 79-81
a=10.369(2)Å b=20.791(3)Å c=8.071(3)Å
α=90.00° β=90.00° γ=90.00°
Cyclomicrobuxine
C25H39NO2,H2O
Acta Crystallographica Section C (2000) 56, 2 233-234
a=6.1333(8)Å b=24.365(3)Å c=8.0681(6)Å
α=90.00° β=108.496(8)° γ=90.00°
Pefloxacinium methanesulfonate 0.10 hydrate
C17H21FN3O3,CH3SO3,0.10H2O
Acta Crystallographica Section C (2000) 56, 7 910-912
a=8.111(3)Å b=10.0130(10)Å c=13.277(3)Å
α=101.220(10)° β=102.85(2)° γ=102.010(10)°
Trans-4-thia-1-decalinol p-bromobenzoate
C16H19BrO2S
Acta Crystallographica Section C (2001) 57, 9 1084-1088
a=8.886(2)Å b=5.3714(9)Å c=16.599(3)Å
α=90° β=92.70(2)° γ=90°
N-benzyl-trans-4-aza-1-decalinol p-bromobenzoate
C23H26BrNO2
Acta Crystallographica Section C (2001) 57, 9 1084-1088
a=9.561(2)Å b=9.822(2)Å c=13.202(3)Å
α=78.34(2)° β=78.21(2)° γ=61.92(3)°
Trans-4-oxa-1-decalinol p-bromobenzoate
C16H19BrO3
Acta Crystallographica Section C (2001) 57, 9 1084-1088
a=9.643(2)Å b=10.679(2)Å c=8.772(2)Å
α=96.32(2)° β=111.32(2)° γ=110.49(2)°
N-benzyl-cis-4-aza-1-decalinol p-bromobenzoate
C23H26BrNO2
Acta Crystallographica Section C (2001) 57, 9 1084-1088
a=11.914(3)Å b=13.144(3)Å c=6.922(2)Å
α=96.06(2)° β=106.22(2)° γ=100.42(3)°
Cis-4-oxa-1-decalinol p-bromobenzoate
C16H19BrO3
Acta Crystallographica Section C (2001) 57, 9 1084-1088
a=10.906(2)Å b=8.052(4)Å c=17.195(3)Å
α=90° β=95.98(2)° γ=90°
Tri-n-butyltin-N-(1-naphthyl)-maleamate
C26H37NO3Sn
Acta Crystallographica Section C (2002) 58, 6 m334-m335
a=9.5705(7)Å b=11.7377(9)Å c=12.4726(11)Å
α=97.011(3)° β=107.571(4)° γ=102.297(6)°
3,3-dimethyl-3-(trichlorogermyl)propionic acid
C5H9Cl3GeO2
Acta Crystallographica Section C (2005) 61, 1 m51-m54
a=15.526(4)Å b=11.521(4)Å c=11.828(6)Å
α=90.00° β=98.423(15)° γ=90.00°
3,3-dimethyl-3-(tri-p-tolylgermyl)propionic acid
C26H30GeO2
Acta Crystallographica Section C (2005) 61, 1 m51-m54
a=20.041(3)Å b=9.370(2)Å c=12.816(5)Å
α=90.00° β=108.436(9)° γ=90.00°
3,3-dimethyl-3-(triphenylgermyl)propionic acid
C23H24GeO2
Acta Crystallographica Section C (2005) 61, 1 m51-m54
a=7.7850(10)Å b=15.678(2)Å c=32.703(5)Å
α=90.00° β=96.668(5)° γ=90.00°
1,3,5-tri-tert-butyl-2,4-difluoro-6-phenylcyclotriborazane
C18H32B3F2N3
Acta Crystallographica Section C (2005) 61, 1 o47-o49
a=13.653(4)Å b=13.637(5)Å c=11.893(4)Å
α=90.00° β=112.19(3)° γ=90.00°
N-(2-chlorophenyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
C16H13ClN2O4S
Acta Crystallographica Section C (2008) 64, 1 o4-o6
a=7.970(5)Å b=10.945(6)Å c=11.133(7)Å
α=60.61(3)° β=69.81(3)° γ=86.32(2)°
N-(2-chlorophenyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide
C16H13ClN2O4S
Acta Crystallographica Section C (2008) 64, 1 o4-o6
a=7.750(2)Å b=28.588(7)Å c=7.5190(10)Å
α=90.00° β=106.630(12)° γ=90.00°
2-[N-(2-chlorophenyl)carbamoyl]benzenesulfonamide
C13H11ClN2O3S
Acta Crystallographica Section C (2008) 64, 5 o286-o289
a=15.734(9)Å b=10.614(6)Å c=7.717(3)Å
α=90.00° β=90.00° γ=90.00°
2-[N-(4-chlorophenyl)carbamoyl]benzenesulfonamide
C13H11ClN2O3S
Acta Crystallographica Section C (2008) 64, 5 o286-o289
a=7.435(2)Å b=16.006(6)Å c=22.061(7)Å
α=90.00° β=90.00° γ=90.00°
Trichloromethylimidoyl-4-methoxybenzamidine
C10H10Cl3N3O
Acta Crystallographica Section C (2011) 67, 8 o273-o277
a=12.0988(10)Å b=8.6425(7)Å c=12.2023(10)Å
α=90.00° β=107.4450(10)° γ=90.00°
Trichloromethylimidoyl-4-bromobenzamidine
C9H7BrCl3N3
Acta Crystallographica Section C (2011) 67, 8 o273-o277
a=5.8124(17)Å b=23.379(7)Å c=9.715(3)Å
α=90.00° β=107.407(3)° γ=90.00°
Trichloromethylimidoyl-4-chlorobenzamidine
C9H7Cl4N3
Acta Crystallographica Section C (2011) 67, 8 o273-o277
a=5.762(2)Å b=22.711(8)Å c=9.713(4)Å
α=90.00° β=106.031(4)° γ=90.00°
Trichloromethylimidoylbenzamidine
C9H8Cl3N3
Acta Crystallographica Section C (2011) 67, 8 o273-o277
a=10.2999(3)Å b=10.9423(3)Å c=15.6902(4)Å
α=85.5518(12)° β=86.5092(12)° γ=81.5436(11)°
Trichloromethylimidoyl-4-trifluoromethylbenzamidine
C10H7Cl3F3N3
Acta Crystallographica Section C (2011) 67, 8 o273-o277
a=11.2939(17)Å b=8.3914(13)Å c=13.505(2)Å
α=90.00° β=95.505(2)° γ=90.00°
(<i>E</i>)-3-(4-Chlorophenyl)-2-phenylprop-2-enoic acid
C15H11ClO2
Acta Crystallographica Section E (2009) 65, 7 o1562
a=14.405(3)Å b=5.733(9)Å c=15.416(9)Å
α=90.00° β=100.72(3)° γ=90.00°
4-Chloro-<i>N</i>-cyclohexylbenzamide
C13H16ClNO
Acta Crystallographica Section E (2009) 65, 7 o1539
a=14.755(14)Å b=5.043(7)Å c=16.818(16)Å
α=90.00° β=96.13(6)° γ=90.00°
4-Methylbenzenecarbothioamide
C8H9NS
Acta Crystallographica Section E (2010) 66, 6 o1271
a=9.7341(5)Å b=5.8391(2)Å c=13.9055(6)Å
α=90.00° β=104.946(3)° γ=90.00°
2-(3,4-Dimethyl-5,5-dioxo-2<i>H</i>,4<i>H</i>- pyrazolo[4,3-<i>c</i>][1,2]benzothiazin-2-yl)-<i>N</i>'-(2- thienylmethylidene)acetohydrazide
C18H17N5O3S2
Acta Crystallographica Section E (2010) 66, 6 o1265-o1266
a=18.5474(2)Å b=11.6670(5)Å c=8.4783(7)Å
α=90.00° β=90.00° γ=90.00°
4-Hydroxy-3-(3-methoxybenzoyl)-2-[(3-methoxybenzoyl)methyl]-2<i>H</i>-1,2- benzothiazine 1,1-dioxide
C25H21NO7S
Acta Crystallographica Section E (2010) 66, 9 o2314-o2315
a=10.3169(2)Å b=10.6923(3)Å c=11.6867(3)Å
α=115.5965(11)° β=105.8041(14)° γ=97.6128(13)°
Ethoxycarbonylmethyl 3-(4-chlorobenzylidene)dithiocarbazate
C12H13ClN2O2S2
Acta Crystallographica Section E (2010) 66, 10 o2545
a=7.3425(3)Å b=10.3894(4)Å c=10.6457(5)Å
α=116.535(2)° β=95.049(2)° γ=94.955(2)°
2-(3,4-Dimethyl-5,5-dioxo-2<i>H</i>,4<i>H</i>- pyrazolo[4,3-<i>c</i>][1,2]benzothiazin-2-yl)-<i>N</i>'-(3- methoxybenzylidene)acetohydrazide dimethylformamide hemisolvate
C21H21N5O4S,0.5(C3H7NO)
Acta Crystallographica Section E (2011) 67, 1 o216-o217
a=18.3806(5)Å b=8.1155(2)Å c=30.4715(5)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>'-(2-Chlorobenzylidene)-2-(3,4-dimethyl-5,5-dioxo-2<i>H</i>,4<i>H</i>- pyrazolo[4,3-<i>c</i>][1,2]benzothiazin-2-yl)acetohydrazide
C20H18ClN5O3S
Acta Crystallographica Section E (2011) 67, 1 o218-o219
a=11.4881(2)Å b=12.7518(3)Å c=15.5690(4)Å
α=71.2778(11)° β=78.6837(13)° γ=70.4911(12)°
24-Methyllanosta-7,25-dien-3-one
C31H50O
Acta Crystallographica Section E (2010) 66, 3 o626
a=6.72070(10)Å b=19.4804(5)Å c=20.5035(5)Å
α=90.00° β=90.00° γ=90.00°
2-(2-Oxo-2-phenylethyl)-1,2-benzisothiazol-3(2<i>H</i>)-one 1,1-dioxide
C15H11NO4S
Acta Crystallographica Section E (2010) 66, 3 o616
a=8.0730(2)Å b=9.1270(3)Å c=18.0143(6)Å
α=90.00° β=95.4616(18)° γ=90.00°
2-[2-(3-Chlorophenyl)-2-oxoethyl]-1,2-benzisothiazol-3(2<i>H</i>)-one 1,1-dioxide
C15H10ClNO4S
Acta Crystallographica Section E (2010) 66, 3 o617
a=7.7258(4)Å b=9.0780(4)Å c=10.0809(5)Å
α=83.884(3)° β=85.092(3)° γ=87.765(3)°
2-[2-(3-Methoxyphenyl)-2-oxoethyl]-1,2-benzisothiazol-3(2<i>H</i>)-one 1,1-dioxide
C16H13NO5S
Acta Crystallographica Section E (2010) 66, 3 o618
a=8.9824(3)Å b=8.5801(4)Å c=19.5645(7)Å
α=90.00° β=97.942(2)° γ=90.00°
5α-Dihydrovespertilin acetate
C24H36O4
Acta Crystallographica Section E (2010) 66, 3 o598
a=6.4256(3)Å b=9.6527(6)Å c=34.953(2)Å
α=90.00° β=90.00° γ=90.00°
(4-Hydroxy-1,1-dioxo-2<i>H</i>-1,2-benzothiazin-3-yl)(3-methoxyphenyl)methanone
C16H13NO5S
Acta Crystallographica Section E (2010) 66, 5 o1021
a=8.1866(3)Å b=7.2431(3)Å c=25.2452(9)Å
α=90.00° β=95.5869(18)° γ=90.00°
Ranunculin
C11H16O8
Acta Crystallographica Section E (2010) 66, 10 o2503
a=5.7944(4)Å b=6.9359(3)Å c=15.0491(10)Å
α=90.00° β=97.895(2)° γ=90.00°
4-(4-Bromophenyl)-6-(4-chlorophenyl)pyrimidin-2-ylamine
C16H11BrClN3
Acta Crystallographica Section E (2009) 65, 2 o390
a=39.343(8)Å b=3.851(2)Å c=22.620(6)Å
α=90.00° β=123.81(2)° γ=90.00°
O-Methyl cyclolaudenol
C32H54O
Acta Crystallographica Section E (2009) 65, 6 o1202
a=6.8812(2)Å b=8.5040(3)Å c=47.7465(9)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(4-Nitrophenyl)cinnamamide
C15H12N2O3
Acta Crystallographica Section E (2009) 65, 9 o2068
a=5.903(3)Å b=15.050(9)Å c=14.388(9)Å
α=90.00° β=95.38(3)° γ=90.00°
<i>N</i>-acetonylsaccharin
C10H9NO4S
Acta Crystallographica Section E (2009) 65, 9 o2185
a=7.475(3)Å b=8.975(4)Å c=15.923(7)Å
α=90.00° β=101.028(18)° γ=90.00°
<i>N</i>-(2-Chlorophenyl)-4-hydroxy-2<i>H</i>-1,2-benzothiazine-3-carboxamide 1,1-dioxide
C15H11ClN2O4S
Acta Crystallographica Section E (2009) 65, 9 o2279-o2280
a=10.077(2)Å b=13.818(3)Å c=21.426(4)Å
α=90.00° β=97.070(13)° γ=90.00°
4,4,6-Trimethyl-1-(3-methylphenyl)-3,4-dihydropyrimidine-2(1<i>H</i>)-thione
C14H18N2S
Acta Crystallographica Section E (2010) 66, 3 o635
a=10.5904(3)Å b=16.9189(5)Å c=30.5713(10)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>'-[(<i>E</i>)-4-(Diethylamino)benzylidene]-4-nitrobenzohydrazide monohydrate
C18H20N4O3,H2O
Acta Crystallographica Section E (2010) 66, 4 o1007-o1008
a=38.3142(12)Å b=7.4563(3)Å c=12.6332(5)Å
α=90.00° β=98.215(2)° γ=90.00°
(20<i>S</i>)-20-Acetamido-18-chloro-5α-pregnan-3β-yl acetate
C25H40ClNO3
Acta Crystallographica Section E (2010) 66, 4 o933
a=7.6604(4)Å b=9.7796(4)Å c=16.8301(8)Å
α=90.00° β=96.398(2)° γ=90.00°
3-Benzoyl-4-hydroxy-2-methyl-2<i>H</i>-1,2-benzothiazine 1,1-dioxide
C16H13NO4S
Acta Crystallographica Section E (2010) 66, 4 o968
a=6.8342(3)Å b=9.9085(3)Å c=10.7234(4)Å
α=83.257(2)° β=79.481(2)° γ=85.113(2)°
<i>N</i>-Saccharinylmethyl ether
C16H12N2O7S2
Acta Crystallographica Section E (2010) 66, 4 o929
a=8.9317(4)Å b=18.3681(6)Å c=10.1942(5)Å
α=90.00° β=93.517(2)° γ=90.00°
(3-Chlorophenyl)(4-hydroxy-1,1-dioxo-2<i>H</i>-1,2-benzothiazin-3-yl)methanone
C15H10ClNO4S
Acta Crystallographica Section E (2010) 66, 4 o885
a=4.7151(3)Å b=12.2879(8)Å c=12.5809(6)Å
α=81.375(3)° β=84.463(3)° γ=85.608(3)°
(<i>E</i>)-3-(2-Chloro-6-methyl-3-quinolyl)-1-(2,3-dihydro-1,4-benzodioxin-\ 6-yl)prop-2-en-1-one
C21H16ClNO3
Acta Crystallographica Section E (2010) 66, 4 o744
a=6.370(3)Å b=38.735(9)Å c=7.409(4)Å
α=90.00° β=114.93(2)° γ=90.00°
3-Benzoyl-4-hydroxy-2<i>H</i>-1,2-benzothiazine 1,1-dioxide
C15H11NO4S
Acta Crystallographica Section E (2010) 66, 4 o862
a=13.8675(4)Å b=7.6289(2)Å c=25.7553(9)Å
α=90.00° β=102.4519(12)° γ=90.00°
4-Nitro-<i>N</i>'-[(<i>E</i>)-3-pyridylmethylidene]benzohydrazide
C13H10N4O3
Acta Crystallographica Section E (2010) 66, 4 o976
a=14.6158(3)Å b=8.1969(2)Å c=10.3645(2)Å
α=90.00° β=100.6090(10)° γ=90.00°
<i>N</i>'-(3-Methoxybenzylidene)-4-nitrobenzohydrazide monohydrate
C15H13N3O4,H2O
Acta Crystallographica Section E (2010) 66, 4 o977-o978
a=6.7162(3)Å b=7.4929(3)Å c=32.1141(15)Å
α=91.883(2)° β=91.5697(12)° γ=112.753(2)°
(2<i>E</i>)-3-(2-Chloro-6-methyl-3-quinolyl)-1-(1-naphthyl)prop-2-en-1-one
C23H16ClNO
Acta Crystallographica Section E (2010) 66, 4 o761
a=16.919(8)Å b=7.146(3)Å c=14.829(5)Å
α=90.00° β=103.29(2)° γ=90.00°
4-Nitro-<i>N'</i>-[(1<i>E</i>,2<i>E</i>)-3-phenylprop-2-en-1- ylidene]benzohydrazide
C16H13N3O3
Acta Crystallographica Section E (2010) 66, 5 o1022
a=16.4236(17)Å b=5.3360(5)Å c=17.1073(18)Å
α=90.00° β=114.578(5)° γ=90.00°
(<i>E</i>)-3-(3-Chlorophenyl)-1-(4-methoxyphenyl)prop-2-en-1-one
C16H13ClO2
Acta Crystallographica Section E (2010) 66, 6 o1346-o1347
a=10.3415(6)Å b=3.89380(10)Å c=16.9152(10)Å
α=90.00° β=107.582(2)° γ=90.00°
4-Methoxybenzenecarbothioamide
C8H9NOS
Acta Crystallographica Section E (2010) 66, 6 o1272
a=5.6545(2)Å b=7.3966(2)Å c=38.7497(13)Å
α=90.00° β=90.00° γ=90.00°
Isopropyl 2-(3,4-dimethyl-5,5-dioxo-4<i>H</i>-pyrazolo[4,3-<i>c</i>][1,2]benzothiazin- 2-yl)acetate
C16H19N3O4S
Acta Crystallographica Section E (2010) 66, 10 o2630
a=7.6370(2)Å b=8.5412(2)Å c=13.3096(4)Å
α=98.4584(18)° β=97.4870(13)° γ=95.9599(17)°
4-Hydroxy-2-[(4-iodobenzoyl)methyl]-3-(3-methoxybenzoyl)-2<i>H</i>- 1,2-benzothiazine 1,1-dioxide
C24H18INO6S
Acta Crystallographica Section E (2010) 66, 9 o2327
a=9.7392(2)Å b=11.5288(3)Å c=20.4634(4)Å
α=90.00° β=100.5288(11)° γ=90.00°
<i>N</i>,<i>N</i>'-Di-<i>tert</i>-butyl-<i>N</i>''-(2-chloroacetyl)phosphoric triamide
C10H23ClN3O2P
Acta Crystallographica Section E (2011) 67, 11 o2848
a=16.4781(5)Å b=9.8872(2)Å c=19.6509(6)Å
α=90.00° β=111.5747(12)° γ=90.00°
<i>N</i>,<i>N</i>'-Bis(2-chlorobenzyl)-<i>N</i>''-(2,2,2- trichloroacetyl)phosphoric triamide
C16H15Cl5N3O2P
Acta Crystallographica Section E (2011) 67, 8 o2046
a=9.9789(2)Å b=10.6058(3)Å c=10.8386(3)Å
α=75.8920(13)° β=72.2250(15)° γ=69.6050(15)°
(2-Bromophenyl)(4-hydroxy-1,1-dioxo-2<i>H</i>-1,2-benzothiazin-3-yl)methanone
C15H10BrNO4S
Acta Crystallographica Section E (2012) 68, 4 o1247
a=12.0433(4)Å b=8.5491(3)Å c=14.7841(5)Å
α=90.00° β=106.3950(19)° γ=90.00°
<i>N</i>-Benzyl-4-hydroxy-2-methyl-1,1-dioxo-2<i>H</i>-1λ^6^,2- benzothiazine-3-carboxamide
C17H16N2O4S
Acta Crystallographica Section E (2012) 68, 6 o1921
a=8.785(3)Å b=9.122(3)Å c=11.425(4)Å
α=66.61(2)° β=87.66(2)° γ=69.38(2)°